US Patent 11136317 NADPH oxidase 4 inhibitors

Patent 11136317 was granted and assigned to Actelion on October, 2021 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Patent Inventor Names

Sylvia Richard-Bildstein0

Martin Bolli0

Patrick Sieber0

Christoph Boss0

Hamed Aissaoui0

Date of Patent

October 5, 2021

Patent Application Number

20200130

Date Filed

January 30, 2020

Patent abstract

The invention relates to 2,5-disubstituted benzoxazole and benzothiazole derivatives of Formula (I)

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 11136317 NADPH oxidase 4 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.